Status:
UNKNOWN
Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery
Lead Sponsor:
Liverpool University Hospitals NHS Foundation Trust
Conditions:
Covid19
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
trial to assess the effectiveness of pre-operative screening for COVID-19 in patients undergoing elective cancer surgery.
Detailed Description
1. Background: The optimal method of screening patients for COVID infection before elective cancer surgery is unclear. Provisional data from the international COVIDsurg audit as well as a similar ...
Eligibility Criteria
Inclusion
- participants capable of giving informed consent,
- gender: Male and Female
- Age: 18 years and above
- Preoperative cancer patients (elective)
- Willing to be contacted by phone after hospital discharge
- Patients listed for inpatient admission postoperatively (cancer patients)
Exclusion
- Cancer patients who require non-cancer surgery
- emergency cancer operations
- Patients under the age of 18
- Patients who do not have capacity to consent
- Cancer patients not requiring an inpatient stay postoperatively
- Patients who it was not anticipated would require an inpatient stay preoperatively but required admission after surgery
Key Trial Info
Start Date :
June 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 25 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04449783
Start Date
June 25 2020
End Date
September 25 2020
Last Update
July 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Liverpool University Hospitals NHS Foundation Trust
Liverpool, Merseyside, United Kingdom, L9 7AL